Phase 4 Lupus Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults aged 18 or older who have been diagnosed with a specific type of kidney disease called lupus nephritis (class III, IV, III/IV, or III/V), confirmed by a kidney biopsy
• People whose kidneys are functioning at a moderate level or above, based on a specific kidney function blood test (eGFR of 30 or higher)
• People who have a high level of protein in their urine, measured by a specific urine test (protein creatinine ratio above 1000 mg/g)

Who may not be able to join:

• People who have had a serious allergic reaction (such as severe swelling or anaphylaxis) to the study drug, empagliflozin
• People whose kidney function falls below a certain level on the eGFR blood test (below 30)
• People whose urine protein level is below the required threshold on the urine test (below 1000 mg/g)
• People who have been diagnosed with Type 1 or Type 2 diabetes
• People who have been diagnosed with atrial fibrillation (an irregular heartbeat condition)
• People with significant liver problems, based on specific liver blood test results at the time of enrolment (confirm with trial site)
• People who have another serious health condition — unrelated to the kidney or heart — where their treating doctor estimates a life expectancy of less than 6 months
• People who have participated in another experimental clinical study within the past 6 months

Important: Always verify eligibility with the trial site directly before applying.